• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过指数富集实现复杂靶标的配体系统进化的进展]

[Advancements in complex target systematic evolution of ligands by exponential enrichment].

作者信息

Wu Zhenning, Xue Shujiang, Yang Yongjie

机构信息

Agricultural College of Yanbian University, Yanji 133002, China.

出版信息

Se Pu. 2018 Oct 8;36(10):947-951. doi: 10.3724/SP.J.1123.2018.05019.

DOI:10.3724/SP.J.1123.2018.05019
PMID:30378352
Abstract

Nucleic acid aptamers are single-stranded oligonucleotides that possess high affinity and specificity. They are also known as "chemical antibodies" and have a wide range of applications. Aptamers are usually generated by an in vitro process termed as systematic evolution of ligands by exponential enrichment (SELEX). Aptamers are often selected by employing purified soluble protein targets. However, the process of protein purification can be complex and laborious. Furthermore, several protein targets, such as low abundance proteins found in serums and membrane proteins found in cells, are difficult to purify. Complex target SELEX can avoid the purification step and maintain the native state of the target proteins. Even in the absence of detailed composition and characterization of a complex target, complex target SELEX can be performed with a high throughput for obtaining specific aptamers. In this study, complex target SELEX taken unpurified biological samples as targets will be described in order to provide a new idea for researchers screening aptamers.

摘要

核酸适体是具有高亲和力和特异性的单链寡核苷酸。它们也被称为“化学抗体”,具有广泛的应用。适体通常通过一种称为指数富集配体系统进化(SELEX)的体外过程产生。适体通常通过使用纯化的可溶性蛋白质靶标来筛选。然而,蛋白质纯化过程可能复杂且费力。此外,一些蛋白质靶标,如血清中发现的低丰度蛋白质和细胞中发现的膜蛋白,很难纯化。复杂靶标SELEX可以避免纯化步骤并保持靶标蛋白的天然状态。即使在没有复杂靶标详细组成和表征的情况下,复杂靶标SELEX也可以高通量进行以获得特异性适体。在本研究中,将描述以未纯化的生物样品为靶标的复杂靶标SELEX,以便为研究人员筛选适体提供新思路。

相似文献

1
[Advancements in complex target systematic evolution of ligands by exponential enrichment].[通过指数富集实现复杂靶标的配体系统进化的进展]
Se Pu. 2018 Oct 8;36(10):947-951. doi: 10.3724/SP.J.1123.2018.05019.
2
Complex target SELEX.复杂靶标指数富集的配体系统进化技术
Acc Chem Res. 2008 Jan;41(1):130-8. doi: 10.1021/ar700142z.
3
SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.SELEX——一种用于生成高亲和力核酸配体的革命性方法。
Biomol Eng. 2007 Oct;24(4):381-403. doi: 10.1016/j.bioeng.2007.06.001. Epub 2007 Jun 16.
4
Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.解析朊病毒蛋白与适配体及其他朊病毒蛋白结合核酸的相互作用
Int J Mol Sci. 2017 May 17;18(5):1023. doi: 10.3390/ijms18051023.
5
Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.利用核酸类似物提高适体性能:从头设计和 SELEX 后方法。
Trends Biotechnol. 2022 May;40(5):549-563. doi: 10.1016/j.tibtech.2021.09.011. Epub 2021 Oct 28.
6
The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.SELEX条件对筛选与细菌细胞结合的适体过程中所得适体库的影响。
J Mol Evol. 2015 Dec;81(5-6):194-209. doi: 10.1007/s00239-015-9711-y. Epub 2015 Nov 4.
7
Artificial Intelligence in Aptamer-Target Binding Prediction.适体-靶点结合预测中的人工智能
Int J Mol Sci. 2021 Mar 30;22(7):3605. doi: 10.3390/ijms22073605.
8
An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.一种用于筛选与化脓性链球菌M11型结合的DNA适配体的改良SELEX技术。
Methods. 2016 Mar 15;97:51-7. doi: 10.1016/j.ymeth.2015.12.005. Epub 2015 Dec 8.
9
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.细胞特异性适体的开发:最新进展及选择程序的见解。
Molecules. 2017 Nov 27;22(12):2070. doi: 10.3390/molecules22122070.
10
SELEX methods on the road to protein targeting with nucleic acid aptamers.SELEX 方法在利用核酸适体进行蛋白质靶向中的应用。
Biochimie. 2018 Nov;154:132-155. doi: 10.1016/j.biochi.2018.09.001. Epub 2018 Sep 5.